Home | Terms of Use | Privacy Statement | Contact Us For U.S. healthcare professionals only.
		For Pharmacists   Video Watch a Biological  Video online...   Biological Activity of Kepivance® How Kepivance® reduces the incidence and duration of severe oral mucositis in patients with hematologic malignancies requiring HSCT. Indication and Usage Information regarding when Kepivance® should be used and how it is supplied. Pharmacodynamics of Kepivance® Specific information about the effect of Kepivance® on areas afflicted by oral mucositis. Precautions Safety information that should be known when recommending Kepivance®. ABOUT ORAL MUCOSITIS ABOUT KEPIVANCE® TOOLS AND RESOURCES FOR NURSES FOR PHARMACISTS IMPORTANT PRODUCT SAFETY INFORMATION
	Kepivance® is indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy requiring hematopoietic stem cell support. The safety and efficacy of Kepivance® have not been established in patients with non-hematologic malignancies. Important Safety Information In patients with hematologic malignancies, the most common serious adverse reaction in clinical trials attributed to Kepivance® was skin rash reported in less than 1% of patients.   Contact | Reimbursement | Biovitrum.com | Site Map Prescribing Information © 2008 Biovitrum AB (publ). All rights reserved.